BAA CONTRACT - DEVELOPMENT OF SUSCEPTIBILITY GUIDANCE FOR DAPTOMYCIN AND ENTEROCOCCUS SPECIES USING PHARMACOMETRIC APPROACHES
$325,000
| Recipient | INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC. UEI Z82HHPY83MC7 |
|---|---|
| Award ID | 75F40126C00025 |
| Award amount | $325,000 |
| Award type | DEFINITIVE CONTRACT |
| Awarding agency | Department of Health and Human Services — Food and Drug Administration |
| NAICS | 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) |
| PSC | B529 |
| Set-aside | Unrestricted |
| Start date | Aug 1, 2026 |
| End date | Jul 31, 2027 |
| Place of performance | SCHENECTADY, NY |
| Record updated | Jul 8, 2026 |
View the official award record
More awards won by INSTITUTE FOR CLINICAL PHARMACODYNAMICS, INC.
COMBATTING ANTIBIOTIC RESISTANT BACTERIA (CARB) PROGRAM
Department of Health and Human Services · $291,618 · Sep 21, 2022
A STUDY IN THE "DEVELOPMENT OF MODERNIZED SUSCEPTIBILITY GUIDANCE FOR ORAL SULFAMETHOXAZOLE-TRIMETHOPRIM USING PHARMACOMETRICS APPROACHES" BAA PMWP #195
Department of Health and Human Services · $291,142 · Sep 22, 2022
THIS IS A FIRM FIXED PRICE CONTRACT FOR DEVELOPMENT OF MODERNIZED SUSCEPTIBILITY GUIDANCE FOR AMPICILLIN AND VANCOMYCIN FOR ENTEROCOCCUS SPECIES USING PHARMACOMETRIC APPROACHES
Department of Health and Human Services · $263,016 · Sep 18, 2023
PRE-CLINICAL MODELS OF INFECTIOUS DISEASES - TASK AREA C
Department of Health and Human Services · No current value reported · Jul 15, 2024
Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.
Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.
Search open bids